LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 11 of 166
Next
>>
>
251 to 275 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	OSI-027	3.33	uM	LJP6	72	hr	1097	1671	3673	0.4548	0.2723
BT-20	OSI-027	10	uM	LJP6	72	hr	1097	1275	3673	0.3473	0.0898
BT-20	WYE-125132	0.12	uM	LJP6	72	hr	1097	1399	3673	0.3809	0.1495
BT-20	WYE-125132	0.37	uM	LJP6	72	hr	1097	1319	3673	0.3592	0.1115
BT-20	AT-7519	0.04	uM	LJP6	72	hr	1097	3026	3673	0.8238	0.7896
BT-20	AZD7762	0.37	uM	LJP6	72	hr	1097	2115	3673	0.5756	0.4564
BT-20	JW-7-24-1	1.11	uM	LJP6	72	hr	1097	2370	3673	0.6458	0.5549
BT-20	KIN001-043	0.12	uM	LJP6	72	hr	1097	3483	3673	0.9487	0.9403
BT-20	AT-7519	0.12	uM	LJP6	72	hr	1097	1875	3673	0.5105	0.3589
BT-20	AT-7519	0.37	uM	LJP6	72	hr	1097	832	3673	0.2262	-0.1485
BT-20	AT-7519	3.33	uM	LJP6	72	hr	1097	540	3673	0.1468	-0.3382
BT-20	AT-7519	10	uM	LJP6	72	hr	1097	529	3673	0.1442	-0.3420
BT-20	AZD7762	1.11	uM	LJP6	72	hr	1097	1307	3673	0.3559	0.1055
BT-20	AZD7762	3.33	uM	LJP6	72	hr	1097	750	3673	0.2042	-0.1962
BT-20	AZD8055	0.04	uM	LJP6	72	hr	1097	1423	3673	0.3873	0.1601
BT-20	AZD8055	0.12	uM	LJP6	72	hr	1097	1170	3673	0.3188	0.0367
BT-20	AZD8055	3.33	uM	LJP6	72	hr	1097	906	3673	0.2468	-0.1038
BT-20	AZD8055	10	uM	LJP6	72	hr	1097	119	3673	0.0326	-0.7198
BT-20	Sorafenib	0.12	uM	LJP6	72	hr	1097	3487	3673	0.9497	0.9413
BT-20	Sorafenib	0.37	uM	LJP6	72	hr	1097	3050	3673	0.8306	0.7963
BT-20	GW843682X	0.04	uM	LJP6	72	hr	1097	3006	3673	0.8188	0.7820
BT-20	Palbociclib	3.33	uM	LJP6	72	hr	1097	1567	3673	0.4265	0.2267
BT-20	PF562271	0.04	uM	LJP6	72	hr	1097	3406	3673	0.9268	0.9131
BT-20	Afatinib	3.33	uM	LJP6	72	hr	1097	3253	3673	0.8856	0.8654
BT-20	Afatinib	1.11	uM	LJP6	72	hr	1097	3152	3673	0.8581	0.8317

|<
<<
Previous
Page 11 of 166
Next
>>
>
251 to 275 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)